
Allena Pharmaceuticals ALNA
Quarterly report 2022-Q2
added 08-15-2022
Allena Pharmaceuticals ROA Ratio 2011-2026 | ALNA
Annual ROA Ratio Allena Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -140.01 | -84.37 | -138.79 | -54.65 | -22.49 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -22.49 | -140.01 | -88.06 |
Quarterly ROA Ratio Allena Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -149.07 | -131.53 | -160.46 | -159.24 | -133.63 | -130.16 | -121.85 | -93.63 | -84.37 | -91.32 | -109.66 | -124.8 | -138.79 | -120.22 | -95.84 | -76.05 | -54.65 | -46.85 | -37.13 | -28.68 | -22.49 | -28.13 | -35.67 | -30.86 | -24.97 | -12.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -12.4 | -160.46 | -86.25 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-241.53 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-22.19 | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
6.02 | $ 16.89 | -2.37 % | $ 789 M | ||
|
AgeX Therapeutics
AGE
|
-275.96 | - | -10.17 % | $ 12.2 K | ||
|
Compugen Ltd.
CGEN
|
22.57 | $ 2.85 | -5.94 % | $ 266 M | ||
|
I-Mab
IMAB
|
7.43 | - | - | $ 866 M | ||
|
Coherus BioSciences
CHRS
|
65.04 | $ 1.58 | -3.37 % | $ 185 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
23.87 | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
8.97 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-24.26 | $ 7.46 | -4.73 % | $ 204 M | ||
|
Athira Pharma
ATHA
|
-114.6 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
-40.14 | - | 0.74 % | $ 768 M | ||
|
Galera Therapeutics
GRTX
|
2071.28 | - | -32.59 % | $ 7.61 M | ||
|
Eton Pharmaceuticals
ETON
|
-4.99 | $ 29.73 | -0.77 % | $ 800 M | ||
|
Exelixis
EXEL
|
27.51 | $ 50.09 | -1.98 % | $ 13.6 B | ||
|
Midatech Pharma plc
MTP
|
-35.12 | - | -18.52 % | $ 27.3 M | ||
|
Fortress Biotech
FBIO
|
19.94 | $ 2.47 | 7.39 % | $ 68.9 M | ||
|
Forte Biosciences
FBRX
|
-83.81 | $ 22.53 | -5.97 % | $ 292 M | ||
|
Fennec Pharmaceuticals
FENC
|
-13807.03 | $ 9.51 | 2.92 % | $ 272 M | ||
|
AbCellera Biologics
ABCL
|
-10.79 | $ 4.03 | -8.52 % | $ 1.2 B | ||
|
Autolus Therapeutics plc
AUTL
|
-48.81 | $ 1.57 | -1.26 % | $ 418 M | ||
|
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - | ||
|
BioNTech SE
BNTX
|
-5.17 | $ 88.94 | -3.32 % | $ 21.5 B | ||
|
Checkmate Pharmaceuticals
CMPI
|
-77.89 | - | - | $ 231 M | ||
|
Galectin Therapeutics
GALT
|
-157.87 | $ 2.22 | -5.74 % | $ 142 M | ||
|
Gilead Sciences
GILD
|
14.42 | $ 129.56 | -1.9 % | $ 161 B | ||
|
Genmab A/S
GMAB
|
17.12 | $ 26.79 | -0.41 % | $ 1.73 B | ||
|
Advaxis
ADXS
|
-289.96 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-103.3 | $ 3.36 | -5.62 % | $ 5.53 M | ||
|
Aeterna Zentaris
AEZS
|
-48.33 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-19.95 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-35.55 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-27.57 | - | - | $ 26.5 M | ||
|
Grifols, S.A.
GRFS
|
0.99 | $ 7.67 | -1.6 % | $ 5.21 B | ||
|
AIkido Pharma
AIKI
|
-19.87 | - | 1.93 % | $ 17.4 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
53.1 | $ 0.72 | -1.76 % | $ 32.9 M | ||
|
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | ||
|
Esperion Therapeutics
ESPR
|
-4.87 | $ 3.13 | 0.32 % | $ 651 M | ||
|
Aptose Biosciences
APTO
|
-254.37 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-97.25 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
-31.09 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-11.27 | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
-35.68 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
-76.23 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-3.73 | $ 21.66 | 0.42 % | $ 2.76 B |